The Imperial study is far bigger, scrutinising data from nearly 300,000 patients in 175 hospital trusts between 2000 and 2008.
而此次帝国学院的研究范围更大,详查的数据覆盖了2000到2008年间175家医院的30万名患者。
The drug is being developed by one of the world's leading obesity experts, Professor Steve Bloom at Imperial College London's Hammersmith Hospital campus.
这个药物是由一位世界领先的肥胖症专家,伦敦帝国理工学院哈默史密斯医学院的Steve Bloom教授研发的。
应用推荐